Euglobulin lysis time

A blood sample is needed.

Follow the instructions that tell you how long before the test you need to stop exercising. Heavy exercise can cause a shorter-than-normal ELT time.

When the needle is inserted to draw blood, some people feel moderate pain. Others feel only a prick or stinging. Afterward, there may be some throbbing or slight bruising. This soon goes away.

This is one of the best tests to tell the difference between primary fibrinolysis and disseminated intravascular coagulation (DIC). Primary fibrinolysis is the normal breakdown of blood clots. DIC is disease that prevents blood from clotting normally.

The test can also be used to monitor people who are taking streptokinase or urokinase after a heart attack. These are medicines that prevent blood clots.

A normal value will range from 90 minutes to 6 hours. Euglobulin clot lysis is normally complete within 2 to 4 hours.

Normal value ranges may vary slightly among different laboratories. Some labs use different measurements or test different samples. Talk to your health care provider about the meaning of your specific test results.

A longer-than-normal ELT time may be due to:

• Diabetes
• Prematurity (baby being born too early)

A shorter-than-normal ELT time may be due to:

• Blood vessel injury or surgery
• Cancer of the prostate
• Liver cirrhosis
• Fibrinogen deficiency (fibrinogen is a protein in the blood that helps it clot)
• Leukemia
• Pregnancy complications (for example, antepartum hemorrhage, hydatidiform mole, amniotic embolism)
• Shock
• A bleeding disorder called thrombocytopenia purpura

The test may also be done to diagnose or rule out:

• Miscarriage
• A bone marrow disorder called primary thrombocythemia

There is a very little risk from having your blood taken. Veins and arteries vary in size so it may be harder to take a blood sample from one person than another.

Other slight risks from having blood drawn may include:

• Excessive bleeding
• Fainting or feeling lightheaded
• Hematoma (blood accumulating under the skin)
• Infection (a slight risk any time the skin is broken)

Euglobulin clot lysis; Fibrinolysis/euglobulin lysis; ELT

Laffan MA, Manning R. Investigation of a thrombotic tendency. In: Bain BJ, Bates I, Laffan MA, Lewis SM, eds. Dacie and Lewis Practical Haematology. 11th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2012;chap 19.

Mitsios JV, Rand JH. Laboratory approach to thrombotic risk. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 23rd ed. St Louis, MO: Elsevier; 2017:chap 41.

Updated by: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.